Upstate Active Clinical Trials

Study Title:

RTOG 1016 - Phase III Trial of Radiotherapy Plus Cetuximab Versus Chemoradiotherapy in HPV-Associated Oropharynx Cancer

What is the purpose of the study?

This phase III trial is studying radiation therapy with cisplatin or cetuximab to see how well it works in treating patients with oropharyngeal cancer.

Upstate Institutional Review Board (IRB) Number:

351373

Study Phase:

III

Patient Age Group:

Adults

Principal Investigator:

Michael A Lacombe, MD

ClinicalTrials.Gov ID:

NCT01302834

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Dena R Martin
Phone: 315-464-5262
Email: martind@upstate.edu

Return to Previous Page || Search Again